|Articles|February 7, 2008
July 2007 BPA Statement
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Eli Lilly to acquire Adverum Biotechnologies
2
Regeneron receives another CRL for its Eylea 8 mg
3
Anti-VEGF innovations in retinal disease: From molecules to medicine
4
SparingVision doses first patient in NYRVANA clinical trial of SPVN20 for retinitis pigmentosa
5














































.png)


